بدائل البحث:
increase decrease » increased release (توسيع البحث), increased crash (توسيع البحث)
all decrease » small decrease (توسيع البحث), fold decrease (توسيع البحث), awd decreased (توسيع البحث)
a decrease » _ decrease (توسيع البحث), _ decreased (توسيع البحث), _ decreases (توسيع البحث)
increase decrease » increased release (توسيع البحث), increased crash (توسيع البحث)
all decrease » small decrease (توسيع البحث), fold decrease (توسيع البحث), awd decreased (توسيع البحث)
a decrease » _ decrease (توسيع البحث), _ decreased (توسيع البحث), _ decreases (توسيع البحث)
-
1721
-
1722
-
1723
-
1724
Data Sheet 1_Ribosomal protein L9 is a potential therapeutic target for B-ALL through the activation of the p53 signaling pathway.docx
منشور في 2025"…In this study, we observed a significant upregulation of RPL9 in human B-ALL cells compared to normal B cells, suggesting RPL9’s potential key role in B-ALL progression. …"
-
1725
-
1726
Table 2_To MRAs treatment or not? evidence from a meta-analysis of randomized controlled trials of different MRAs on cardiovascular health in heart failure.docx
منشور في 2025"…However, MRA therapy was associated with an increased risk of renal dysfunction, including hyperkalemia (RR = 2.086, 95% CI: 1.872–2.325, p < 0.001; I<sup>2</sup> = 0.0%), elevated serum creatinine (RR = 1.512, 95% CI: 1.252–1.825, p < 0.001; I<sup>2</sup> = 0.0%), decreased eGFR (WMD = −5.223, 95% CI: −7.380 to −3.066, p < 0.001; I<sup>2</sup> = 0.0%), and potentially increased incidence of composite renal outcomes.…"
-
1727
Table 1_To MRAs treatment or not? evidence from a meta-analysis of randomized controlled trials of different MRAs on cardiovascular health in heart failure.docx
منشور في 2025"…However, MRA therapy was associated with an increased risk of renal dysfunction, including hyperkalemia (RR = 2.086, 95% CI: 1.872–2.325, p < 0.001; I<sup>2</sup> = 0.0%), elevated serum creatinine (RR = 1.512, 95% CI: 1.252–1.825, p < 0.001; I<sup>2</sup> = 0.0%), decreased eGFR (WMD = −5.223, 95% CI: −7.380 to −3.066, p < 0.001; I<sup>2</sup> = 0.0%), and potentially increased incidence of composite renal outcomes.…"
-
1728
Table 3_To MRAs treatment or not? evidence from a meta-analysis of randomized controlled trials of different MRAs on cardiovascular health in heart failure.docx
منشور في 2025"…However, MRA therapy was associated with an increased risk of renal dysfunction, including hyperkalemia (RR = 2.086, 95% CI: 1.872–2.325, p < 0.001; I<sup>2</sup> = 0.0%), elevated serum creatinine (RR = 1.512, 95% CI: 1.252–1.825, p < 0.001; I<sup>2</sup> = 0.0%), decreased eGFR (WMD = −5.223, 95% CI: −7.380 to −3.066, p < 0.001; I<sup>2</sup> = 0.0%), and potentially increased incidence of composite renal outcomes.…"
-
1729
Cell viability of alveolar macrophages of MH-S cell line stimulated with SMPs for 24
منشور في 2025الموضوعات: -
1730
-
1731
-
1732
-
1733
Comparison of absolute and relative errors.
منشور في 2025"…A significant reduction in both error types is observed, with the relative error |<i>X</i><sub><i>r</i></sub>| decreasing from approximately 10<sup>−1</sup> to 10<sup>−8</sup>. …"
-
1734
Rate of convergence for relative errors.
منشور في 2025"…A significant reduction in both error types is observed, with the relative error |<i>X</i><sub><i>r</i></sub>| decreasing from approximately 10<sup>−1</sup> to 10<sup>−8</sup>. …"
-
1735
Prescription data.
منشور في 2025"…<div><p>Background</p><p>The COVID-19 pandemic has had a profoundly negative impact on all societal sectors, public health systems, and state economies. …"
-
1736
Table 1_The association between oxidative balance scores and all-cause mortality and cancer-specific mortality in cancer survivors: a retrospective cohort study.doc
منشور في 2025"…Weighted multivariable Cox regression results showed that each unit increase in OBS was associated with a 3% decrease in all-cause mortality (Hazard Ratios [HR]: 0.97, 95% Confidence interval [CI]: 0.95, 0.99, p = 0.006). …"
-
1737
PRISMA flow chart of the screening process.
منشور في 2025"…The analysis showed that pulsatile perfusion led to a significant decrease in creatinine level [MD = −0.14, 95% CI (−0.24, −.04), P < 0.004], lactate level [MD = −8.21, 95% CI (−13.16, −3.25), P < 0.001], hospital stay [MD = −1.38, 95% CI (−2.51, −0.25), P = 0.016], ICU stay [MD = −0.47, 95% CI (−0.82, −0.13), P = 0.007], intubation time [MD = −3.73, 95% CI (−5.42, −2.04), P < 0.001], and increase in creatinine clearance [MD = 10.08, 95% CI (3.36, 16.80), P < 0.003]. …"
-
1738
Forest plot of liver function tests.
منشور في 2025"…The analysis showed that pulsatile perfusion led to a significant decrease in creatinine level [MD = −0.14, 95% CI (−0.24, −.04), P < 0.004], lactate level [MD = −8.21, 95% CI (−13.16, −3.25), P < 0.001], hospital stay [MD = −1.38, 95% CI (−2.51, −0.25), P = 0.016], ICU stay [MD = −0.47, 95% CI (−0.82, −0.13), P = 0.007], intubation time [MD = −3.73, 95% CI (−5.42, −2.04), P < 0.001], and increase in creatinine clearance [MD = 10.08, 95% CI (3.36, 16.80), P < 0.003]. …"
-
1739
Subgroup analysis of BUN based on pump type.
منشور في 2025"…The analysis showed that pulsatile perfusion led to a significant decrease in creatinine level [MD = −0.14, 95% CI (−0.24, −.04), P < 0.004], lactate level [MD = −8.21, 95% CI (−13.16, −3.25), P < 0.001], hospital stay [MD = −1.38, 95% CI (−2.51, −0.25), P = 0.016], ICU stay [MD = −0.47, 95% CI (−0.82, −0.13), P = 0.007], intubation time [MD = −3.73, 95% CI (−5.42, −2.04), P < 0.001], and increase in creatinine clearance [MD = 10.08, 95% CI (3.36, 16.80), P < 0.003]. …"
-
1740
Subgroup analysis of ICU Stay based on pump type.
منشور في 2025"…The analysis showed that pulsatile perfusion led to a significant decrease in creatinine level [MD = −0.14, 95% CI (−0.24, −.04), P < 0.004], lactate level [MD = −8.21, 95% CI (−13.16, −3.25), P < 0.001], hospital stay [MD = −1.38, 95% CI (−2.51, −0.25), P = 0.016], ICU stay [MD = −0.47, 95% CI (−0.82, −0.13), P = 0.007], intubation time [MD = −3.73, 95% CI (−5.42, −2.04), P < 0.001], and increase in creatinine clearance [MD = 10.08, 95% CI (3.36, 16.80), P < 0.003]. …"